# SOFIE Co. dba SOFIE – FDA Inspection, Oct 28, 2025

Source: https://www.keypedia.com/records/fda_inspections/sofie-co-dba-sofie/f23fa115-173f-44cf-b3a9-5ba539fae69c
Source feed: FDA_Inspections

> FDA inspection 1288954 of SOFIE Co. dba SOFIE, October 28, 2025. Classification: Voluntary Action Indicated (VAI). 4 citations under 21 CFR part 212. Form 483 issued. 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1288954
- Company Name: SOFIE Co. dba SOFIE
- Inspection Date: 2025-10-28
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Dallas District Office
- Citation Count: 4

## Related Documents

- FDA Inspection 999635 - 2017-01-04
- FDA Inspection 977923 - 2016-05-06
- FDA Inspection 800995 - 2012-09-27

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/cameron-e-moore/5a879539-24b7-4c54-99e4-b8e31f18ec9b)
- [FDA Associated Person](https://www.keypedia.com/people/camerson-e-moore/50733244-0d55-4b0b-a758-f192b7c66457)

Company: https://www.keypedia.com/companies/sofie-co-dba-sofie/2788a42c-0f99-4a95-8de3-ef2e88c93110

Office: https://www.keypedia.com/offices/dallas-district-office/2d1ee9ae-c44c-4494-8186-a920a69b98f9